Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
glyXera is a leading provider of high-performance glycoanalysis services and products, specializing in the detailed characterization of glycans and glycoproteins. Spun out from the Max Planck Institute for Dynamics of Complex Technical Systems, the company utilizes its proprietary glyXpress platform to deliver high-throughput, high-resolution glycomic and glycoproteomic profiling. Their expertise supports the pharmaceutical and biotechnology industries in the development, optimization, and quality control of biologics, including monoclonal antibodies and vaccines. glyXera offers a comprehensive suite of solutions, including analytical services, specialized kits, and software for complex data analysis. These tools ensure regulatory compliance and accelerated time-to-market for their clients by providing precise structural information on complex carbohydrates.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on glyXera.